Definition Guaifenesin is an oral medication classified as an expectorant, used to relieve chest congestion by aiding the removal of mucus from the airways.
Overview Guaifenesin is commonly used in over-the-counter (OTC) cough and cold remedies to alleviate symptoms associated with respiratory conditions such as acute bronchitis, the common cold, and other respiratory tract infections. It functions by thinning and loosening mucus in the airways, making it easier to expel through coughing. The drug is available in various formulations, including immediate-release and extended-release tablets, syrups, and capsules. It is generally considered safe when used as directed, though excessive doses may lead to gastrointestinal discomfort or dizziness.
Etymology/Origin The name "guaifenesin" is derived from its chemical structure and nomenclature conventions in organic chemistry. It is a derivative of glyceryl guaiacolate, with "guai-" referencing guaiacol, a compound derived from the creosote tree (Laurus guaiacum), and "-fenesin" reflecting its phenolic ether characteristics. Guaifenesin was first synthesized in the 1940s and introduced into clinical use in the United States in the 1950s.
Characteristics
- Chemical formula: C10H14O4
- Molecular weight: 198.22 g/mol
- Mechanism of action: Increases respiratory tract secretions' volume and decreases their viscosity, facilitating mucus clearance.
- Bioavailability: Rapidly absorbed from the gastrointestinal tract; metabolism occurs primarily in the liver via glucuronidation.
- Half-life: Approximately 1 to 2 hours for immediate-release formulations; extended-release forms can maintain therapeutic levels for up to 12 hours.
- Excretion: Mainly eliminated in the urine as glucuronide conjugates.
- Dosage forms: Tablets (including sustained-release), syrups, and liquid-filled capsules.
- Typical adult dose: 200–400 mg every 4 hours or 600–1200 mg every 12 hours for extended-release formulations, not exceeding 2400 mg per day.
- Approved by: The U.S. Food and Drug Administration (FDA) and regulatory agencies in numerous countries for OTC use.
Related Topics
- Expectorants – a class of drugs that promote the expulsion of mucus from the lungs, bronchi, and trachea.
- Mucolytics – agents that chemically break down mucus, differing from expectorants like guaifenesin which primarily alter mucus consistency.
- Upper respiratory tract infections – common conditions for which guaifenesin is indicated.
- Codeine – an opioid sometimes combined with guaifenesin in prescription cough syrups for its antitussive properties.
- Chronic obstructive pulmonary disease (COPD) – a condition where mucus clearance is impaired; guaifenesin may be used off-label in management.
Guaifenesin is not intended to treat the underlying cause of respiratory symptoms or suppress dry, non-productive coughs. It is widely available without a prescription and is included in numerous multi-symptom cold and flu formulations.